Global Wealth Management Investment Advisory’s Lifecore Biomedical LFCR Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-300	Closed	-$2K	–	542
2020 Q2	$2K	Hold	300	–	–	﹤0.01%	519
2020 Q1	$3K	Hold	300	–	–	﹤0.01%	475
2019 Q4	$3K	Hold	300	–	–	﹤0.01%	483
2019 Q3	$3K	Hold	300	–	–	﹤0.01%	462
2019 Q2	$3K	Hold	300	–	–	﹤0.01%	500
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	470
2018 Q4	$4K	Buy	+300	New	+$4.12K	﹤0.01%	510

Other funds holding LFCR

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

CSC

Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return

PRCP

Pacific Ridge Capital Partners Lake Oswego, Oregon $551M AUM 49.99% 1-Year Est. Return

Global Wealth Management Investment Advisory's LFCR Position: Q3 2020 in Review

Global Wealth Management Investment Advisory sold out of Lifecore Biomedical (LFCR) in Q3 2020, closing a stake of 300 shares — an estimated $2K sold.

Global Wealth Management Investment Advisory first reported a position in LFCR in Q4 2018 and held it in 7 quarters. The position peaked at $4K in Q1 2019. 96 funds tracked by Wall St. Rank hold LFCR as of Q3 2020.

Global Wealth Management Investment Advisory reported no remaining Lifecore Biomedical position as of Q3 2020 after selling out during the quarter.
Global Wealth Management Investment Advisory sold 300 Lifecore Biomedical shares in Q3 2020, an estimated $2K.
Global Wealth Management Investment Advisory first reported a position in Lifecore Biomedical in Q4 2018 and held it in 7 quarters.
Global Wealth Management Investment Advisory's Lifecore Biomedical position peaked at $4K in Q1 2019.
96 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2020.

Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2020, filed 16 Nov 2020.